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  Chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers are a leading 
contributor toward mortality throughout the world.  The inability of these wounds to heal is associated with the 
presence of microbial biofilms.  The objective of this study was to determine if products secreted by 
Staphylococcus aureus (S. aureus) biofilms play an active role in chronic wounds by promoting inflammation, 
which is a hallmark of chronic wounds.  
 In vitro experiments were conducted to examine changes in gene expression profiles and inflammatory 
response of human epithelial keratinocytes (HEKa) exposed to products secreted by S. aureus grown in biofilms 
or products secreted by S. aureus grown planktonically.   
After only hours of exposure, gene expression microarray data showed marked differences in 
inflammatory, apoptotic, and nitric oxide responses between HEKa cells exposed to S. aureus biofilm 
conditioned media (BCM) and HEKa cells exposed to S. aureus planktonic conditioned media (PCM).   As early 
as 4 hours post exposure, enzyme linked immonosorbant assay (ELISA) results showed significant increases in 
interleukin 6 (IL-6),interleukin 8 (IL-8), tumor necrosis factor alpha (TNFα), and chemokine ligand 2 (CXCL2) 
production by HEKa cells exposed to BCM compared to HEKa cells exposed to PCM or controls.  Nitric oxide 
assay data also showed significant increases in nitric oxide production by HEKa cells treated with BCM 
compared to HEKa cells treated with PCM, or controls.  These results support and extend previous findings that 
indicate products secreted by S. aureus biofilms directly contribute to the chronic inflammation associated with 
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Chapter 1: Introduction 
 
 Wound Healing  
Skin is the primary barrier between the body and the outside world.  When a break in the skin or 
skin wound occurs it is imperative that it heals in a timely and efficient manner to minimize the ability for 
pathogenic bacteria to colonize [Stadlemann, 1998].  Skin wounds fall in to two categories, acute and 
chronic.  Acute wounds heal in an uncomplicated manner and follow an orderly pattern of healing.  Chronic 
wounds can be defined in a variety of ways, but the most common definition is a wound that takes an 
extended time to heal or does not heal in an orderly fashion using standard therapy [Fletcher, 2008].  Most 
commonly, if a wound has not healed in 4-6 weeks it is considered a chronic wound [Siddiqui and 
Bernstein, 2010].    
   Acute wounds heal quickly, and in a conventional pattern with little or no fibrosis [Stedelmann, 
1998].  This pattern of healing is well-defined and includes: inflammation, proliferation, contraction and 
tissue remodeling [Dieglemann, 2004].  The first phase in the healing process is the inflammatory phase.  
For approximately the first 4 days after injury there is an increased blood supply to the wound site that 
brings in fibronectin, polymorphonuclear leukocytes, and mononuclear leukocytes which mature into 
macrophages and then lymphocytes.  The fibronectin that is deposited in the wound site forms a fibrin clot 
which serves as the matrix that supports the rest of the healing process [Stadelmann et al., 1998]. 
Fibroblasts begin constructing the extracellular matrix by synthesizing a provisional extracellular matrix 
that is subsequently replaced by collagen fibers [Epstein, 1999].  This fibrin clot also provides the 
scaffolding in which fibroblasts migrate to the wound site [James et al., 2008].   After the creation of the 
fibrin clot the keratinocytes surrounding the wound start to produce chemical signals in the form of 
cytokines and chemokines [Stadelmann et al., 1998].  These signals attract neutrophils and monocytes to 
the wound site.   Neutrophils play an important role in the healing process by phagocytizing bacteria that 
may try to colonize the wound site as well as serve as an early source of pro-inflammatory cytokines that 
serve as signals to activate fibroblasts.  While neutrophils are signaling cytokines macrophages are also 





pathogenic microorganisms as well as clearing away any other cell matrices or debris that might be found 
in the site of the wound [James et al., 2008; Serralta et al., 2001]. 
 After the inflammatory phase comes the proliferative phase that can last up to two years [Thomas 
and Harding, 2002].  This phase involves the production of TGF-β which increases the transcription of 
genes responsible for collagen, proteoglycans and fibronectin as well as increasing the overall production 
of matrix proteins.  TGF-β also decreases proteases responsible for the breakdown of the matrix [Thomas 
and Harding, 2002].  Fibroblasts are stimulated by TGF-β1 and other growth factors and completely invade 
the wound about a week after the fibrin clot forms [Darby et al.,1990].   Fibroblasts produce collagen that 
forms the lattice that will eventually lead wound closure [Stadelmann, 1998].  A portion of fibroblast 
transform into myofibroblasts that express α-smooth muscle actin that resembles smooth muscle that 
generates strong contractile fibers [Darby and Gabbiana, 1990].  Keratinocytes play a role in the 
modulation of fibroblasts so that they can transition from deposition of collagen and other elastic fibers to a 
phenotype that functions more in the deposition of ECM and there functions more in the remodeling phase 
[Menon et al., 2012].  This remodeling phase of the healing process stimulates the crosslinking of collagen 
fibers in order to from scar tissue [James et al., 2008].   
Remodeling is the last phase of the acute healing process and allows the wound to form some 
lasting scar tissue.  The collagen fibers that have been formed in previous phases reorganize to produce the 
scar tissue and the final epithelial tissue that ends the healing process [Serralta, 2001].  Even with the 
relative organization of this process acute wound healing can have a variety of outcomes and timelines. The 
amount of scar tissue can vary widely.  In wounds that have excessively long healing rates, hypertonic 
scarring occurs through the excessive production of collagen [Menon et al., 2012].    
 Wounds that exhibit delayed healing or a failure to heal are called chronic wounds.  Chronic 
wounds can occur in the form of diabetic ulcers, pressure sores as well as venous and arterial ulcers.  These 
wounds often come with a variety of issues including impaired granulocytic function, impaired chemotaxis, 
and an increase in the inflammatory phase, impaired neurovalsculation, decreased synthesis of collagen, 
increased levels of proteinases, and defective macrophage function [Epstein, 1999].  During the wound 





inflammatory cells, macrophages, and fibroblasts.  In chronic wounds the creation of this matrix is 
impaired which leads to a delay in healing [Stadelmann, 1998].    
Bacterial colonies are also a common feature of chronic wounds.  These colonies create increased 
inflammation, which increases neutrophil and macrophage migration to the site.  This migration stimulates 
inflammatory cytokines and degrades the extracellular matrix, which causes tissue hypoxia and leads to 
slower or an absence of wound healing at the site [Newton and Dixit, 2012].  
Bacterial Biofilms 
 Bacteria have the ability to grow in two forms: planktonically and in biofilms form. Planktonic 
bacteria live as single cells that are motile and have little or no communication with other bacterial cells 
[Landi et al., 2009].  Biofilms are bacteria that have converted to a sessile form and adhere to a surface.  
Biofilms can result from a variety of environmental cues and consist of multilayers of bacterial cells 
adherent to a biotic or abiotic surface [Chaignon et al. 2007]. The transformations from the planktonic to 
sessile form, and along with the production of polysaccharide intracellular adhesions, are important for the 
formation of bacterial biofilms [Cramton et al., 1999].   
 When bacteria form biofilms they alter their physiology, gene expression and morphology [Landi, 
2007].  The first step to biofilm formation is the adherence of the bacterial cells to a surface.  Bacterial 
biofilms seem to grow most readily on surfaces that are impaired due to systemic disease (like diabetes or 
arthritis) or local factors (arterial insufficiency or venous hypertension).  These damaged areas provide a 
fertile bed for bacterial colonization that can ultimately lead to the formation of bacterial biofilms [Edwards 
and Harding, 2004].  The contact with a favorable surface leads to a series of gene expression changes that 
promote a more stable connection between the bacterial cell and surface [Stanley, 2004].  Two of the genes 
that have been found to play a role in the transformation of S. aureus into its sessile form are ica and sarA 
[Beeken et al., 2003; Cramton et al., 2001].  After conversion of its sessile form bacterial biofilms must 
adhere to the surface.   Bap, which codes for a surface protein, has been shown to play a part in the 





  After cellular adhesion is the formation of the bacteria micro-colony.  Micro-colonies can be 
several layers thick and can be composed of a single species of bacteria or multiple species that depend on 
cell-cell interactions [Stanley, 2004].  The adhesion of bacterial cells in multiple layers is followed by the 
creation of a polysaccharide intercellular adhesion (PIA) portion of the extracellular matrix (ECM) [Gotz, 
2002].  PIA links bacterial cells together and may play a role in the adherence of biofilms to surfaces [Gotz, 
2002].  
 Another important factor to the production and maintenance of bacterial biofilms is quorum 
sensing.  Quorum sensing bacteria produce and release chemical signal molecules called autoinducers that 
lead to an alteration of gene expression.  This alteration allows bacterial cells to secrete chemical signals 
that act as a communication network between the bacterial cells in the micro-colony matrix [Yarwood, 
2004].  This communication network is essential to biofilm formation and the ability of bacteria to resist 
antibacterial properties in wounds and other natural environments [Landini, 2009; Miller and Bassler, 
2001].  In gram-positive cells like S. aureus the bacterial cells communicate using modified oligopeptides 
as signals and a “two-component” type membrane bound sensor histidine kinases as receptors.  Signaling is 
mediated through a response regulator which creates a circuit that mediates intraspecies communication 
[Waters and Bassler, 2005].  This circuit is created by a phosphorylation cascades that influences the 
activity of a DNA-binding transcriptional regulatory protein termed a response regulator [Landini, 2009].  
agr has been found to be upregulated in S. aureus that grown in biofilms.  agr has been found to play a role 
in the secretion of chemical signals that are associated with the creation of the polysaccharide matrix and 
quorum sensing which are essential to the functioning of bacterial biofilms [Schierle et al., 2009].        
 In order to create a bacterial biofilm that would allow us to investigate the genomic and 
inflammatory changes that occur between keratinocytes exposed to planktonic cells and bacterial biofilms 
we used S. aureus.  S. aureus was chosen because it is the most common bacteria found in chronic wounds 
infected with bacterial biofilms and has been used in other studies on chronic wounds [Schierleet et al, 
2009].  These earlier studies have found that S. aureus biofilms prevent re-epithelialization and thus play a 





S. aureus typically is a commensal organism that is a common part of the normal skin flora of 
humans.   But, in the presence of a wound or break in the skin S. aureus can colonize the area and create 
infection [Resch et al., 2005].  A key part of biofilm formation is the creation of the polysaccharide 
intracellular adhesion as part of a polysaccharide matrix which is composed of β-1, 6-linked N-
acetoglucosimine with partially acetylated residues.  The polysaccharide matrix is an essential part in the 
ability of S. aureus biofilms to resist treatment with antibiotics as well as the host immune response [Resch, 
2004]. 
S. aureus and wounds 
 S. aureus is a gram-positive pathogen that can cause a variety of illnesses from food poisoning, 
endocarditis, and toxic shock syndrome and skin illnesses.  S. aureus along with S. epidermis is one of the 
most isolated organisms in acute and chronic skin wounds.  Typically, S. aureus is a commensal organism 
that is present persistently in 30% of the population [Massler and Bassler, 1999].  Often S. aureus is carried 
in the nasal passages and a person’s role as a carrier of S. aureus is a significant risk factor in whether a 
person acquires a staph infection [Wertheim et al., 2005].  In the absence of some break in the skin S. 
aureus carriers are asymptomatic and show no disease.  The pathogenic nature of S. aureus does not occur 
until the pathogen finds some route into the bloodstream where it can create a number of problems for the 
host organisms [Archer, 1998].   
The type and severity of S. aureus infection varies greatly depending on the virulence factors 
involved.  S. aureus pathogenicity is greatly determined by unique forms of virulence genes that exist in 
that clone or lineage [Jarraud et al., 2002].  S. aureus pathogenicity is related to several components found 
on the surface as well as extracellular proteins.  (1) Surface proteins that promote colonization of host 
tissues.   (2) Factors that inhibit phagocytosis (capsule, immunoglobulin binding protein A).  (3) Toxins 
that damage host tissues and cause disease symptoms.  Coagulase-negative staphylococci are normally less 
virulent and express fewer virulence factors.  Staphylococcus epidermis (S. epidermis) readily colonizes 





 In order for the S. aureus pathogen to cause disease it contains several factors that allow it to 
adhere to host cells.  S. aureus surface proteins attach to host proteins such as laminin and fibronectin that 
are a part of the extracellular matrix [Baron, 1996].   A surface protein that is often associated with 
cutaneous skin infections is Panton-Valentine leukocidin.  This protein damages the membranes of the host 
defense cells and erythrocytes [Lina et al., 1999].  Another protein that has been implicated in the ability of 
S. aureus to cause infection and illness is peptidoglycan.  Peptidoglycan has been shown to induce the 
release of inflammatory cytokines in host cells, induce polyclonal activation of T-cells, and cause organ 
injury when it is combined with lipoteichoic acid (LTA)  and lipopolysaccharide (LPS) [Wang et al., 2004].   
Once the S.aureus pathogen has colonized the host it must avoid the host defenses in order to 
propagate itself.  One of the ways that S. aureus avoids elimination in the host is by inhibiting phagocytosis 
through Protein A [Mempel et al., 1998].  Protein A binds to immunoglobin G by the fragment crstallizable 
(Fc) region and disrupts phagocytosis and opsonization [Baron, 1996].  Protein A also allows S. aureus to 
facilitate adhesion to human epithelial cells [Mempel et al., 1998].  It has been found to attach to the 
surface of endothelial cells and stimulate and immune response which includes the stimulation of TNF-α. 
TNF-α is an important immune regulator and can induce fever, stimulate immune cells and induce 
apoptosis.  These immune responses can lead to more severe infection allowing the bacterium to present a 
more invasive disease path [Edwards et al., 2012].  Capsular polysaccharides are also on the surface of the 
S. aureus cell.  These capsular polysaccharides increase the virulence of S. aureus by making the bacterial 
cells more resistant to phagocytosis [O’Riordan and Lee, 2004].  
 The last way that S. aureus is able to circumvent host defenses is through damaging the 
membranes of the host cells.  S. aureus has several toxins that given the right host receptor can adhere 
specific cell receptors and create gaps or pores in the host cells and can lead to sepsis and toxic shock in 
affected hosts [Peacock et al., 2002].  Synergohymenotropic toxins damage membranes of host defense 
cells and erythrocytes.  These toxins are found in more than 99% of S. aureus strains and provide the 
bacterial cell with a way to damage host defense and thus propagate and grow [Lina et al., 1999].  
Expression of most of the virulence factors described above is controlled by the agr locus.  Analysis of the 





produce different disease paths [Jarraud et al., 2002].  This contributes to the overall ability of S. aureus to 
resist host defense and establish and maintain colonization.   
Another key to the ability of S. aureus to infect in a variety of ways is the presence of 
pathogenicity islands.  These parts of the genome carry a high number of genes that are responsible for 
virulence factors which lead to disease in humans and animals [Lindsey and Holden, 2004].  The variety of 
virulence factors is a key factor to the ability of S. aureus to cause a variety of skin infections.  One such 
infection is scalded skin syndrome or Ritter disease.  This type of infection is stimulated by exfoliative 
toxin and causes blisters on human skin [Yamaguchi et al., 2002].  The main role of exoproteins is to 
convert the host tissues into nutrients needed for bacterial growth [Dinges et al., 2000].  As a whole many 
factors play a role in the ability of S. aureus to cause disease and resist the host immune system.   Growth 
in the form of a biofilms is one of those devices [Stewart and Costerton, 2001].  The quorum-sensing 
system regulates which toxins and virulence factors are produced in S. aureus biofilms.  This system allows 
the biofilm to better evade host defenses that the bacteria does in planktonic form [Costerton et al., 2007].            
Keratinocytes  
Skin has three layers; a top layer of a keratinized stratified epidermis, a collagen rich dermal layer 
and a subcutaneous layer.  In unwounded skin a basal layer of keratinocytes attaches to the basal lamella.  
When a cutaneous wound occurs, the top layer of skin is disrupted and colonization of bacteria can occur.  
This colonization can lead to infection that creates significant morbidity and mortality for patients 
[Beckrich and Aronovitch, 1999 Boyko et al. 1996, Landi et al. 2007].  Keratinocytes must form a 
monolayer through migration and only then can the underlying basal layer of stratified epidermis be formed 
[Martin, 1997].  In normal wound healing collagenase is expressed consistently and stimulates the 
migration of keratinocytes to the wound site and this promotes reepithelialization.  The failure of the 
keratinocyte monolayer formation and delayed reepithelialization is characteristic of chronic wounds 
[Saarilho-Kere, 1994].  During wound healing keratinocytes undergo numerous gene expression changes 
and therefore are an appropriate cell type for the study of gene expression changes as well as cytokine and 






Chapter 2: Early effects of Staphylococcus aureus biofilm secreted products on inflammatory 
responses of human epithelial keratinocytes 
 
Background 
 Each year millions of people are stricken with chronic wounds such as diabetic foot ulcers, 
pressure ulcers, and venous leg ulcers that contribute toward morbidity and mortality in the U.S. annually 
[Beckrich and Aronovitch, 1999; Boyko et al., 1996; Landi et al., 2007].  Recent evidence indicates that 
bacterial biofilms are present in chronic wounds more often than in acute wounds and are related to the 
wounds inability to heal [Gjodsbol et al., 2006; James et al., 2008; Serralta et al., 2001].  Bacterial biofilms 
consist of bacterial communities embedded in a self-made extracellular polysaccharide matrix that are often 
resistant to a variety of antibiotics [Stewart and Costerton, 2001].  Chronic wounds provide an excellent 
environment for this matrix due to the tissue surface for growth, poor blood flow, and poor oxygen flow 
that inhibit host cell defenses against the bacteria [Kirker et al., 2009].  The surface of chronic wounds 
allow bacteria to readily adhere to a surface  and relinquish their planktonic state to form an aggregate of 
bacteria that enable the newly formed biofilms to better survive in their environment [Gotz, 2002].  The 
inhibitions of the host cell defenses allow the bacteria to cooperate in the distribution of nutrients, removal 
of wastes, and to resist host defense mechanisms [Serralta, 2001].  
  The establishment of Staphylococcus aureus (S. aureus) biofilms in chronic wounds relies on the 
bacterial community’s ability to adhere to tissue.  After attachment, the bacteria rapidly secrete cell 
signaling molecules that coordinate activities of the bacteria through a process known as quorum sensing 
[Fuqua et al., 1994].  Biofilm formation by S. aureus has been shown to be highly dependent on the 
staphylococcal accessory regulator (sarA) [Beenken et al., 2004] and to a certain degree on the (icaABCD) 
operon [Beenken et al., 2003; Crampro et al.1999; Deluarie et al., 2012; Valle et al., 2003;], and the walRK 
operon [Resch et al., 2005].  Mutations in either sarA or the ica operon have been associated with reduced 
capacity of S. aureus to form biofilms.  There is significant evidence that the molecules in the matrix of 
biofilms lead to impermeability to antibiotics and host defenses [Thurlow et al., 2011].  While the idea that 
biofilms affect wound healing has been established, the exact role of biofilms in chronic wounds is not well 





to resolve and more likely to become chronic or recurrent infections in part due to the inhibition of the re-
epithelialization process [Schierle et al., 2009].   
   Wound healing is a complex series of pathogen and host cell interactions.  Most chronic skin 
wound healing is mediated by keratinocytes [Loo and Halliwell, 2009; Singer and Clark, 1999].  The ability 
of keratinocytes to migrate to the site of the wound and respond to inflammatory signals to eliminate 
infection and complete the process of reepithelialization is important to the ability of chronic wounds to 
heal [Singer and Clark, 1999].  Keratinocytes have been shown to express toll-like receptors 1-6 and 9, 
which can allow them to act as a first responder against pathogenic microorganisms.  For example, S. 
aureus can activate nuclear transcription factor kB (NF-κB) in keratinocytes.  Activated NF-κB then 
translocate into the nucleus and induces the transcription of NF-κB controlled genes such as interleukin 8 
(IL-8) and nitric oxide synthase (iNOS) [Mempel et al. 2003; Miller 2008].  The role that keratinocytes 
play in wound pathogenesis makes them an excellent model to investigate the pathogenesis of wound 
healing in vitro.     
Inflammatory response of the host is important to the ability of wounds to heal.  Biofilms have 
been shown to contribute to the failure of wounds to reepithelialize through the activation of the β-
catenin/c-myc pathways which is in part attributed to the unresponsiveness of cells at the wounds edge 
[Cook et al. 2000; Hasan et al. 1997; Stojadinovic et al. 2005].  A part of that inflammatory response is the 
production of inflammatory cytokines that serve to mediate host immune responses.  Recent evidence has 
revealed that S. aureus biofilms affect the gene regulation and cytokine production of keratinocytes and 
thus may affect the way that wounds heal [Secor et al., 2011].  The goal of this project was to further 
investigate and compare the effects of S. aureus biofilm secreted products and S. aureus planktonic 
secreted products on gene expression profiles and inflammatory responses of human epithelial 
keratinocytes (HEKa).  The hypothesis is that products secreted by S. aureus growing as a biofilm actively 
impair wound healing by promoting inflammatory responses in keratinocytes.  To test this hypothesis, we 
investigated and compared inflammatory responses of HEKa cells exposed to BCM and PCM at both 







Preparation of biofilm conditioned media.   An overnight culture of S. aureus ATCC 6538 in 5.0 ml of 
tryptic soy broth (TSB) was incubated statically at 37
o 
C for 24 hours.  Tissue culture inserts were placed in 
a 24 well plate and inoculated with 10 μl of overnight culture and 500 μl of TSB and inoculated at 37
o 
C for 
72 hours.  Every 24 hours during that 72 hour period the TSB supernatant was removed, the inserts were 
moved to new wells in the 24 well plates, and 500 μl of fresh TSB was added to the wells.  At the end of 72 
hour period the TSB was removed and 500 μl of phosphate buffered saline pH 7.4 (PBS) was added and 
left for 1 hour to wash the remaining TSB from the tissue culture insert.  After the removal of the PBS, 500 
μl of Epilife media (Invitrogen, Carlsbad, CA) was added and incubated for 24 hours at 37
o 
C.  The new 
biofilm conditioned media was then removed from the well and filtered with a 0.45 μm syringe and 
collected in 15 ml centrifuge tubes.  This BCM collecting and filtering procedure was repeated every 24 
hours for 3 days.  The collected BCM was then pooled and frozen at -20
o 
C until it was needed.  
Preparation of planktonic conditioned media.   An overnight culture was created by inoculating a colony 
of S. aureus ATCC 6538 into 5.0 ml of TSB for 24 hours at 37
o 
C on a rotary shaker set at 150 rpm.  After 
incubation the S. aureus culture was centrifuged for 7 minutes at 1500 rpm.  The supernatant was then 
replaced with PBS, and the pellet was re-suspended by thoroughly mixing with a pipette.  The S. aureus 
was then centrifuged for 7 minutes at 1500 rpm and the PBS was decanted.  Five milliliters of Epilife 
media with human keratinocyte growth supplement was then added to the washed S. aureus culture and 
mixed thoroughly with a pipette.  The S. aureus in the Epilife media was then incubated for 24 hours at 37
o 
C on a rotary shaker set at 150 rpm.  After 24 hours the culture was centrifuged at 1500 rpm for 7 minutes 
and the supernatant was decanted and filtered with a 0.45 μm syringe and stored at -20
o 
C until needed.   
Culturing of human keratinocytes.  HEKa cells (Invitrogen, Carlsbad, CA) were seeded into a T-25 and 
T-75 tissue culture flasks at 1 x 10
4 
cells/ml along with Epilife media with human keratinocyte growth 
supplement and 100 μg/ml and 100 U/ml of pen/strep and incubated at 37
o 
C in a CO2 incubator.  Every 48 
hours the Epilife media was changed until the cells reached 80-90% confluence.  In our hands, HEKa cells 
would start to become senescent at about passage 8 or 9.  To prevent cell senescent from altering the results 





XTT HEKa cell viability assay.  BCM and PCM that was created previously were warmed to room 
temperature and diluted to1 mg/ml in Epilife media with human keratinocyte growth supplement.  HEKa 
cells were cultured until they were at 80-90% confluence and then the original Epilife media with human 
keratinocyte growth supplement  media was removed and 300 μl of either the PCM, BCM or media was 
added to the wells in triplicate and incubated for 0, 2, 4, 8, 24, and 48 hours.  At the designated time 60 μl 
of activated 2, 3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) solution 
was added and absorbance read at 450 nm on a Thermo Scientific Multiskan MCC micro plate reader 
(Fisher Scientific, Pittsburgh PA). 
Genomic responses, statistics and bioinformatics analyses.  HEKa cell genomic responses to PCM, 
BCM and Epilife media were also evaluated.  HEKa cells were cultured and plated in a 24 well plate as 
described above and were grown to 80-90% confluence.  After reaching 80-90% confluence the cells were 
exposed to 1.0 ml of PCM, BCM or Epilife media for a period of 0 and 2 hours.  At the designated times 
points the BCM, PCM, and Epilife media was removed, and the cells liberated from the wells for RNA 
extraction using Qiagen RNAeasy Cell Protect kit (Qiagen Inc. Valencia, CA).  The concentrations of the 
RNA were determined using a Nanodrop spectrophotometer (Fisher Scientific, Pittsburgh PA).  RNA was 
diluted to a 0.1 μg/ml concentration in RNase-free water and transported to Oklahoma Medical Research 
Foundation (OMRF) for microarray analysis.  RNA quality was assessed using capillary gel electrophoresis 
(2100 Bioanalyzer, Agilent Technologies, Santa Clara, CA).  Samples were labeled using Illumina 
TotalPrep RNA Amplification kit (Ambion/Life Technologies, Carlsbad, CA) and hybridized to whole 
genome gene expression microarrays (Illumina Human HT-12 v4 BeadChips, Illumina Inc., San Diego, 
CA) according to manufacturers’ instructions.  Microarrays were stained and washed under high stringency 
conditions and were then scanned on an Illumina iSCAN scanner.  Signal intensity values were obtained 
using Genome Studio software (Illumina, v2011.1) and quantile normalized and log transformed using 
MatLab software (Mathworks, Inc., Natick MA) prior to importing into BRB-Array Tools ( National 
Cancer Institute, Biometric Research Branch, Rockville, MD).  Genes were then filtered using the Log 
Expression Variance Filter to screen out genes that are not likely to be informative based on the variance of 
each gene across the arrays.  Biological replicates for each group were designated and statistically 





1.5 fold change between the BCM and the PCM samples [Benjamin et al., 1995].  Bioinformatics analyses 
of differentially expressed genes were performed using Ingenuity Pathways Analysis software (Ingenuity 
Systems, Redwood City, CA).   
Detection of inflammatory cytokines.  HEKa cells were cultured to 80-90% confluence in 24 well plates 
1.0 ml of BCM, PCM or Epilife media without pen/strep was added in triplicate cultures for periods of 0, 2, 
4, and hours.  At the designated time points the BCM, PCM and Epilife media was collected and stored in 
1.5 ml microcentrifuge tubes at -20
o 
C until ELISA tests were performed.  The concentrations of cytokines 
in the PCM, BCM, and Epilife media products that were exposed to HEKa cells were quantified and 
analyzed.  Quantification of TNF-α IL-1, IL-6, and IL-8 was performed using the corresponding 
Quantikine Colorimetric sandwich ELISA assay kit (R&D Systems, Minneapolis, MN) following the 
manufacturer’s instructions.  CXCL2 was quantified using Abnova Enzyme-Linked Immunoabsorbant 
Sandwich Elisa Assay Kit (Abnova Industries, Taipei City, Taiwan).         
Nitric oxide detection.  Cell culture supernatants were collected, and the accumulation of nitrite (NO2
−
), a 
stable end product of NO formation, was measured as an indicator of NO production.  The concentration of 
nitrite in the samples was calculated from a standard curve of sodium nitrite [Granger et al., 1991].  Briefly, 
at four and eight hours post exposure one hundred microliters of supernatants were collected from HEKa 
cells exposed to PCM, BCM, or control media samples and  added in triplicate to the 96 well plates.  One 
hundred microliters of Griess reagent was then added to all wells and incubated at room temperature for 15 
minutes, and then absorbance was measured at 570 nm.   After incubation the optical densities of each well 
were read on a Thermo Scientific Multiskan MCC micro plate reader (Fisher Scientific, Pittsburgh PA) at 
570 nm.   
Statistical analysis.  
 
To determine if there were significant differences in the cell viability of HEKa cells 
exposed to PCM, BCM and the control media two-tailed t-tests were completed.  To determine if there 
were significant differences in the mean concentration of the cytokines or nitric oxide between three types 
of materials, two-tailed t-tests were completed along with ANOVA and Tukey’s statistical methods. An 
ANOVA resulting in a significant p-value (p < 0.05) was followed by Tukey’s Honestly Significant 







HEKa cell viability.  HEKa cell viability experiments were conducted to determine at which point in time 
if any products secreted by S. aureus growing as a biofilm or S. aureus growing planktonically significantly 
reduced viability of HEKa cells.  The XTT viability assay was used to determine the loss of HEKa viability 
after exposure to PCM, BCM, or Epilife media.  After 8 hours exposure there was a significant reduction of 
keratinocyte viability in PCM and BCM exposed cells (Figure 1).  Based on these results it was established 
that sampling time points of 2 hours for microarray analysis and 4 and 8 hours for inflammation analysis 
would be used.   
Transcriptional responses of HEKa cells exposed to BCM or PCM.  We predicted that HEKa cells 
exposed to S. aureus biofilm secreted products would display differential genes expression when compared 
to HEKa cells exposed to S. aureus planktonically secreted products or the media controls.  To test this 
hypothesis we extracted HEKa cellular RNA after 2 hours of exposure to BCM, PCM, or media controls 
and subjected the RNA to Illumina microarray analysis in order to evaluate differential gene expression.  
The data was filtered so that only genes that had a 1.5 fold changes or greater over the media control were 
shown (Table 1).  Analysis revealed that HEKa cells that were exposed to BCM as well HEKa cells 
exposed to PCM had genes associated with inflammation, apoptosis, and nitric oxide production were 
upregulated when compared to the media controls.  When cells exposed to BCM were compared to those 
cells exposed to PCM, the cells exposed to BCM had an increase in the number and fold increase of 
transcriptional products.  The microarray analysis identified 43 genes that were uniquely expressed in BCM 
exposed HEKa cells with a 1.5 or greater fold change in expression that were not expressed in HEKa cells 
exposed to PCM or the media control (Table 1).  Of these genes 42 had an upregulation of expression over 
the control.  Of these upregulated genes, 19 are associated with inflammatory response in eukaryotic cells.  
Eleven genes associated with inflammation were also differentially expressed in HEKa cells exposed to 
PCM, 9 of which were also differentially expressed in cells exposed to BCM (Table 2) and (Figure 2A).  





inflammatory response versus HEKa cells exposed to BCM were  DUSP1, CXCL2, IL-8, ATF3, IL-6 and 
NFKBIA (Table 1 ).   
 Nitric oxide (NO) is an important molecule for inflammation and the reepithelialization of skin.  
Low concentrations of NO have been found to inhibit adhesion molecule suppression cytokines and 
chemokine synthesis and leukocyte adhesion and migration [Luo and Chen 2005, Rizk et al., 2004].  This 
promotes collagen production either directly or through mediators and thus affects collagen synthesis or 
breakdown in the wound [Schaffer et al., 1996].  While low amounts of NO can be beneficial to wound 
repair large amounts of NO generation has been shown to be toxic, pro-inflammatory, and cause the wound 
to enter a cycle where healing does not occur [Frank et al., 2002; Jones et al., 2010].  Because of this, 
microarray results were filtered to look for genes that are associated with the production of nitric oxide 
(NO).  The results showed that at two hours after treatment there were several differentially expressed 
genes associated with NO production that were uniquely upregulated in HEKa cells exposed to BCM 
(Table 1).  This upregulation was not seen in HEKa cells treated with PCM for two hours.  Of these genes 
DUSP1, JUN, IL-6, and ADM were up regulated the most.  Most of the genes above are linked to the 
production of IFN-γ and TNF-α.  Both IFN-γ and TNF-α have been linked to an increase of NO in human 
keratinocytes [Hick et al., 1992].  Oxidative stress has been found to increase the amount of IFN-γ 
produced by the cells which in turn regulates the transcription of DUSP1 and ADM which ultimately leads 
to increases in apoptosis. IFN-γ along with TNF-α stimulates the production of nitric oxide in keratinocytes 
as a response to oxidative stress [Soneja et al., 2005].  IFN-γ has been found to increase the production of 
NO in keratinocytes as much as 20-30%.  IFN-γ has also been linked to an increase in production of IL-6 
along with NO production [Hashiola et al., 2007].  In addition to upregulation of genes associated with NO 
production, we observed down-regulation of ARG1, which is known to be associated with NO production 
in both BCM and PCM, exposed HEKa cells relative to control media (Table 3) and (Figure 2B).  
Overproduction of ARG1 has been linked to keratinocytes overproducing NO in patients with psoriasis and 
basal carcinomas.  The inhibition of ARG1 may then allow NO to inhibit cell proliferation and the failure 





Inflammatory cytokine responses in HEKa cells exposed to BCM or PCM.  In an effort to corroborate 
the microarray results, we assessed the production of the protein levels of several of the most markedly 
upregulated genes associated with an inflammatory response.  ELISAs were used to measure the production 
of IL-1, IL-6, IL-8, TNF-α, and CXCL2.  Cytokine measurements were performed at 4 and 8 hours post 
exposure to BCM or PCM.  ELISA data showed that as soon as 4 hours post exposure, there were 
significantly greater (p < 0.05) levels of IL-6, TNF-α, and CXCL2 in HEKa cells exposed to BCM 
compared to HEKa cells exposed to PCM or control media (Figure 3A).  The levels of IL-6 and CXCL2 
were even greater at 8 hours post exposure and the significant differences between the groups were 
maintained (Figure 3B).  In addition to these three cytokines, the levels of IL-8 were also significantly 
greater (p < 0.05) after 8 hours of exposure in HEKa cells exposed to BCM compared to HEKa cells 
exposed to PCM, or controls (Figure 3B).  PCM exposed HEKa cells did not produce significantly greater 
cytokine levels compared to the media controls at either time point.     
NO responses in HEKa cells exposed to BCM or PCM.  The microarray data revealed an increase in the 
expression of genes associated with the production of nitrite in BCM-exposed HEKa cells.  In an effort to 
corroborate these results, we performed nitric oxide assays on the HEKa cell culture supernatants to 
quantify the amount of nitrate produced by the HEKa cells exposed to PCM, BCM and control media.  The 
nitrite assay data showed that HEKa cells exposed to BCM produced significantly greater (p < 0.05) 
amounts of nitrite at both 4 and 8 hours post exposure than HEKa cells exposed to PCM or the media 
controls (Figure 4).  There were no detectable levels of nitrite from the media controls.  
Discussion  
 The data collected in this study reveal a clearer picture of the role that S. aureus biofilms play on 
cultured keratinocytes.  Keratinocytes serve as the primary cell type in the epidermis and primarily function 
in providing a barrier between the external and internal environment.  When breaks in this barrier occur, 
basal keratinocytes migrate to the site and reepithelialization ensues.  Chronic wounds are characterized by 
prolonged inflammation and the failure of wound reepithelization [Kirker et al., 2009].  Chronic wounds 
activate a number of inflammatory pathways that lead to the prevention of keratinocyte migration, growth, 





in chronic wound pathogenesis HEKa cells were chosen for experiments on the effect of biofilms on early 
chronic wound pathogenesis.  Kirker et al. [2009] demonstrated that the viability of HEKa cells was 
significantly reduced when exposed to BCM or PCM for 24 hours.  Results from our HEKa cell viability 
assays showed that viability was significantly reduced by BCM or PCM in as little as 8 hours of exposure 
(Figure 1), indicating that our findings are in general agreement with previous findings of Kirker et 
al.[Kirker et al., 2008].  Visual inspection of the cells showed morphological differences between HEKa 
cells exposed to the two treatment conditions.  Evidence of cellular stress in the form of rounding of cell 
membranes and decreased culture confluence were observed in HEKa cells exposed to BCM after 8 hours 
of exposure that was not seen in HEKa cells exposed to PCM or the control media (data not shown).  Based 
on the viability assay results and these morphological changes, transcriptional changes were measured at 
two hours after treatment to detect early transcriptional changes in cell populations with high viabilities.  
For inflammatory cytokine response and NO production 4 and 8 hour time intervals were used.  These time 
points were selected in an effort to measure downstream effects of transcription and inflammatory 
responses.   
Increased apoptotic effects in HEKa cells exposed to S. aureus biofilm secreted products provides 
greater understanding of the pathogenesis of wound healing.   Decreased cell viability and the inability of 
wounds to heal have been linked to chronic wounds associated with biofilms [Kirker et al., 2008].  Figure 
2C shows alterations in transcription of genes associated with apoptosis in BCM- and PCM-exposed HEKa 
cells.  This correlates with our cell viability data (Figure 1) which reveals a statistically significant loss of 
HEKa cell viability in BCM and PCM after 8 hours.  There are several definitions of what an actual chronic 
wound is, but some common themes are a prolonged inflammatory phase to the wounds and the failure of 
the wound to respond to standard treatments [Fletcher, 2008].  These wounds fail to reepithelialize which is 
due in part to the decrease of cell production and the increase in cell death.  Our data indicate that there is 
an increase in apoptotic effect in HEKa cells exposed to BCM over PCM or the control conditions.   
Microarray analysis was performed on RNA gathered after 2 hours exposed to BCM, PCM, or the 
media control the samples of HEKa cells exposed for 0 hours were used as a control.  The data were then 





responses, apoptosis and nitric oxide production in HEKa cells.  There was an increase in transcriptional 
activity in HEKa cells exposed to BCM for genes associated with inflammation, apoptosis and NO 
production (Figure 2).  In HEKa cells exposed to BCM some of the largest upregulation of transcriptional 
activity came from the genes CXCL2, IL-8, DUSP1, and ATF3.  The DUSP1 gene is important for the 
regulation of p38 activation of LPS-activated macrophages.  The p38 pathway plays a central role in 
multiple pathways associated with inflammatory response in many cell types [Cuenda and Rousseau 2007; 
Schieven 2009].  The p38 MAPK pathway has been found to play a role in the production of inflammatory 
cytokines namely IL-1 and TNF-α but has also been found to contribute to the production of IL-8 in 
response to IL-1 osmotic shock and IL-6 in response to the production of TNF-α [Newton and Dixit, 2012].  
NFKBIA like DUSP1 is an important transcriptional regulator that induces innate and adaptive immune 
responses.  NFKBIA is one of the genes that assist in the regulation of the magnitude and duration of 
inflammatory responses.  One of its key roles is to prevent the inflammatory response from destroying 
excessive amounts of tissue [Newton and Dixit, 2012].  Some of the other genes up regulated are associated 
with the production of inflammatory cytokines or chemokines.  CXCL2, IL-6 and IL-8 are well known 
cytokines or chemokines which play important roles in mediating inflammatory responses to pathogen.  
CXCL2 and IL-8 are pro-inflammatory chemokines that assist in the mediation of neutrophil migration as 
well as the migration of other cellular and humeral factor components to the site of an infection.  TNF-α, 
IL-6 and IL-8 were also upregulated but the fold change in expression over the control was much lower and 
the increase in expression was only seen in HEKa cells exposed to BCM.  TNF-α, IL-6 and IL-1 are all 
multifunctional cytokines with a wide variety of functions.  These three cytokines are interrelated with IL-1 
and TNF-α inducing IL-6 and IL-6 in turn playing a role in the regulation of TNF-α [Abraham et al., 2000].  
TNF-α plays a role in tissue repair, inflammation and regulation of apoptosis as well as the activation of 
transcriptional factors such as NFΚB that are important to several processes including growth, death, and 
inflammation and stress responses [Banno et al., 2004].  While NF-κB is not regulated at the RNA level 
and is not be expected to be differentially expressed, Ingenuity Pathways Analysis software predicted its 
increased activation based on the expression patterns of 28 genes in the microarray results from BCM-
treated but not PCM-treated HEKa cells relative to media controls (p = 1.06 x 10
-11
).  DUSP1 is produced 





protein-tyrosine phosphatase family which inactivates MAPKs.  MAPKs play an important role in the 
human cellular response to environmental stress as well in the negative regulation of cellular proliferation 
[Lie et al., 2008].  This can lead to an increase in cell death and thus contribute to   S. aureus biofilms’ 
negative effects on the ability of HEKa cells ability to respond to bacterial challenges and prevent apoptosis 
and promote reepithelialization.   
Seven cytokines or chemokines commonly produced by keratinocytes in response to pathogens 
were tested using sandwich ELISAs [Abraham et al., 2000; Fahay et al., 1990; Trengove et al., 2000].  
After 4 hours, cells exposed to BCM showed statistically significant increases in concentrations of IL-6, 
TNF-α, and CXCL2 in HEKa cells exposed to BCM over HEKa cells exposed to PCM and the control 
media.  The increase in inflammatory cytokine and chemokine responses after 4 hours of exposure to PCM, 
BCM, and the media control were in general agreement with earlier research by Secor et al. [2001] who 
showed increases in inflammatory responses by HaCaT cells exposed to S. aureus biofilm products.  HEKa 
cells exposed to PCM, BCM and the control media were also tested by ELISA’s for the same seven 
cytokines and chemokines.  After 8 hours of exposure, levels of IL-8, along with previously elevated IL-6, 
TNF- α, and CXCL2 significantly increased in HEKa cells exposed to BCM over HEKa cells exposed to 
PCM and the media control.  At the 8 hour time point HEKa cells treated with BCM showed a statistically 
significant increase in cytokines versus HEKa cells treated with PCM.  These findings support the current 
hypothesis that biofilm-secreted products differ and have more dramatic effects than secreted products from 
planktonically grown bacteria which may contribute to difference between chronic and acute wounds 
[James et al., 2008].  The creation of biofilms enables bacteria to increase their interaction with one another 
and thus resist antibacterial and environmental pressures [Serralta et al., 2001].  These biofilms are not only 
a congregate of bacterial cells but are also held together by a polysaccharide matrix.  Understanding the 
components of the exopolysaccharide matrix produced by bacterial biofilms along with the difference in 
morphology of the cells may provide clues to the mechanisms of biofilms and why they produce the 
differential inflammatory responses that we have observed.   
 An unexpected finding from the microarray analysis was the upregulation of genes associated with 





not found in control samples.  Eight of those genes were unique to HEKa cells exposed to BCM and were 
not found in HEKa cells exposed to planktonically secreted products.  Despite the genes associated with 
nitric oxide production there was not a significant upregulation of iNOS or NOS2 which are most often 
associated with nitrite production in cells.  The lack of significant iNOS an NOS2 upregulation may have 
been due to the short time between the exposure of the HEKa cells to the PCM and BCM and the time of 
mRNA collections.  Schnorr et al.[2003] reported that iNOS expression in keratinocytes was not detected 
until 4-8 hours after exposure to inflammatory cytokines and maximal expression does not occur until 24 
hours post exposure [Schnorr et al., 2003].  Nitric oxide plays a key role in acute wound repair.  Nitric 
oxide synthesis increases wound healing by enhancing collagen deposition within the wound and in dermal 
fibroblasts to enhance the mechanical strength of the tissue [Granger et al., 1991; Rizk et al., 2004].  
However, high concentrations NO may actually inhibit healing [Schaffer et al., 1996].  In this study, we 
observed upregulation of genes associated with NO production in cells treated with BCM, and tested the 
downstream effects of such genes by performing nitrite assays on culture supernatants.  These nitrite assays 
were done in order to measure nitrite as an index of NO formation.  Statistically significant increases in the 
amount of nitrite produced by HEKa cells exposed to BCM compared to HEKa cells exposed to PCM or 
just Epilife media were detected.  These results add to the understanding of NO role in chronic wounds as 
opposed to acute wounds.  The role of NO in biofilm production and dispersal is controversial.  Falsetta et 
al. [2010] found that in terms of Neisseria gonorrhea biofilms there was a high level of NO which seemed 
to aid the biofilm’s growth.  Other studies have found that NO has been linked to the dispersal of 
Pseudomonas aeruginosa biofilms as well the prevention of biofilm formation in S.aureus and Escherichia 
coli [Barraud et al., 2009; Cai et al., 2012].  It has been suggested that the disparate results are due to 
concentration of NO that is induced in the system.  NO in large concentrations can be toxic to eukaryotic 
cells and in fact eukaryotic cells have developed defenses like metallothionein in response to oxidative 
stress [Frank et al., 2002].  Our results show that NO production by HEKa cells increased over time (Figure 
4) as inflammatory effects of biofilm secreted products increased (Figure 3).  Overproduction of reactive 
nitrogen species can impair cellular migration, proliferation, and synthesis of extracellular matrix that is 





coupled with our results makes NO and its role in biofilm formation, dispersal, and/or chronic wound 
pathogenesis a topic that requires further investigation.  
 The majority of studies on immune responses to bacteria have been carried out with planktonically 
growing bacteria or cell components from planktonically growing bacteria.  Infections due to S. aureus are 
characterized by strong inflammatory responses [Fournier et al., 2005; Nakane et al., 1995].  Several 
molecules such as Panton-Valentine leukocidin [Konig et al., 1995] sphingomyelinase [Waley et al., 1996], 
peptidoglycan, lipoteichoic acid [Wang et al., 2000; Wang et al., 2004], superantigens [Dauwalder et al., 
2006] as well as others have been shown to play a role in the inflammatory response directed towards S. 
aureus.  It is possible that some of these same molecules may be responsible for the differences in 
inflammatory and nitric oxide responses we have measured; however, these molecules have not been 
specifically linked to S. aureus biofilms and chronic wound inflammation.  
Conclusion 
Studies presented in this investigation further our understanding of the role that S. aureus biofilms may 
play in chronic wound pathogenesis.  We found greater transcriptional activity in HEKa cells exposed to 
BCM compared to HEKa cells exposed to PCM or the media controls.  The increased transcriptional 
activity was corroborated by increases in inflammatory cytokine production, nitric oxide production, and 
reduced cell viability.  The increase in nitrite production in HEKa cells exposed to BCM is an intriguing 
finding that could be an important biofilm-mediated factor that contributes to the failure of chronic wounds 
to heal and warrants further investigation.  Experiments to further understand the role of nitric oxide in 
chronic wounds and studies to identify S. aureus biofilm secreted factors responsible for the increased 








Figure 1. HEKa Cell Viability  
HEKa cells were treated with Media, PCM or BCM for up to 8 hours.  At 0, 2, 4, and 8 hours post exposure 
XTT was added and the absorbance read at 540 nm.  Results represent the mean and standard deviation of 
three independent experiments. Percent viabilities are stated as percent viable of untreated controls at each 
time point. 
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Figure 2. Venn diagrams representing the number of genes that were altered in HEKa cells exposed 
to BCM (on the right), PCM (on the left), or shared genes (in the middle). 
The Venn diagram (A) represents genes associated with inflammation, (B) represents genes associated with 












Figure 3. ELISA results for PCM, BCM, and control HEKa cells. 
HEKa cells were treated with Media, PCM or BCM for up to 8 hours. The levels of cytokine production 
were measured after 4 and 8 hours of exposure. (A) Cytokine measurements after 4 hours of exposure. (B) 
Cytokine measurement after 8 hours of exposure. Measurements are reported in pg/ml concentrations. 
Analysis of variance (ANOVA) and Tukey’s Honestly Significant Difference were performed to identify 
statistically significant differences.  Results represent the mean and standard deviation of three independent 
experiments. (#) indicates a significant difference between PCM and BCM and (*) indicates a statistically 





















Figure 4. Nitrite Assay 
HEKa cell culture supernatants were collected and treated with Griess Reagent and absorbance was 
measured at 570 nm. Measurements were taken at 4 and 8 hours.  Measurements are reported in µM. 
ANOVA and Tukey’s Honestly Significant Difference were performed to identify statistically significant 
differences. Results represent the mean and standard deviation of three independent experiments.  (#) 
indicates a statistically significant difference between the PCM and BCM and (*) indicates a statistically 













Table 1. Change in gene expression profiles for genes that were uniquely expressed in BCM exposed 
HEKa cells after 2 hours of exposure. Genes identified through Illumina microarray results filtered to 
represent a 1.5 or greater fold change over the expression in the control sample.  “-“indicates less than a 1.5 
fold change in expression over the control sample.   
Gene Symbol (function) 
Fold-change BCM v 
Control 
Fold-change  PCM v 
Control 
CXCL2 (inflammation) 15.082 - 
IL8 (inflammation) 9.530 - 
DUSP1 (inflammation/NO prod.) 9.061 - 
IL6 (inflammation/NO prod.) 4.623 - 
NFKBIA (inflammation) 4.093 - 
EFNA1 (inflammation) 3.990 - 
TNFAIP3 (inflammation) 3.964 - 
ADM (inflammation/NO prod.) 2.917 - 
CXCL1 (inflammation) 2.850 - 
IL1B (inflammation/NO prod.) 2.586 - 
ZFP36 (inflammation) 2.540 - 
IFI27 (inflammation) 2.411 - 
TNF (inflammation/NO prod.) 2.333 - 
IL1A (inflammation/NO prod.) 2.113 - 
PTGS2 (inflammation/NO prod.) 2.084 - 
SMAD7 (inflammation) 2.073 - 
IL20 (inflammation) 1.655 - 
IL24 (inflammation) 1.540 - 
MMP1 (inflammation) -1.650 - 
FOS (apoptosis) 8.433 - 
ZC3H12A (apoptosis) 4.361 - 
NR4A2 (apoptosis) 4.121 - 
SGK1 (apoptosis) 3.045 - 
CYP1B1 (apoptosis) 2.709 - 
CYR61 (apoptosis) 2.587 - 
BMP2 (apoptosis) 2.481 - 
SLC25A24 (apoptosis) 2.467 - 
CEBPD (apoptosis) 2.419 - 
IFI27 (apoptosis) 2.411 - 
BIRC3 (apoptosis) 1.643 - 
HES1 (growth & proliferation) 4.280 - 
DUSP10_v3  (growth & proliferation) 4.091 - 
EFNA1 (growth & proliferation) 3.990 - 
PPP1R15A (growth & proliferation) 3.582 - 
JUN (growth & proliferation/NO prod.) 3.523 - 
PPP1R10 (growth & proliferation) 3.099 - 
HBEGF (growth & proliferation) 3.053 - 
CYR61 (growth & proliferation) 2.587 - 
CEBPD (growth & proliferation) 2.419 - 
JUNB (growth & proliferation) 2.405 - 
SMAD7 (growth & proliferation) 2.073 - 
DUSP10_v1 (growth & proliferation) 1.764 - 






Table 2. Change in gene expression profiles for genes associated with Inflammation. Genes identified 
through Illumina microarray results filtered to represent a 1.5 or greater fold change over the expression in 
the control sample.   “-“indicates less than a 1.5 fold change in expression over the control sample.   
Gene Symbol 
Fold-change BCM v 
Control 
Fold-change PCM v 
Control 
ATF3 (inflammation) 8.342 1.663 
FOXA2 (inflammation) 3.139 2.715 
BCL6 (inflammation) 2.801 1.515 
SERPINB13 (inflammation 2.513 2.768 
RHOB (inflammation) 2.443 1.464 
MMP28 (inflammation) 2.117 1.672 
IL1F9 (inflammation) 1.662 2.438 
PBK (inflammation) -2.057 -1.882 
TK1 (inflammation) -2.168 -2.029 
CXCL2 (inflammation) 15.082 - 
IL8 (inflammation) 9.530 - 
DUSP1 (inflammation/NO prod) 9.061 - 
IL6 (inflammation) 4.623 - 
NFKBIA (inflammation) 4.093 - 
EFNA1 (inflammation) 3.990 - 
TNFAIP3 (inflammation) 3.964 - 
ADM (inflammation) 2.917 - 
CXCL1 (inflammation) 2.850 - 
IL1B (inflammation/ NO prod) 2.586 - 
ZFP36 (inflammation) 2.540 - 
IFI27 (inflammation) 2.411 - 
TNF Inflammation) 2.333 - 
IL1A (inflammation/ NO prod) 2.113 - 
PTGS2 Inflammation/NO prod) 2.084 - 
SMAD7 (inflammation) 2.073 - 
IL20 (inflammation) 1.655 - 
IL24 (inflammation) 1.540 - 
MMP1 (inflammation) -1.650 - 
IL28RA (inflammation) - 1.589 






Table 3. Gene expression profiles for genes associated with NO production. Genes identified through 
Illumina microarray results filtered to represent a 1.5 or greater fold change over the expression in the 
control sample.  “-“indicates less than a 1.5 fold change in expression over the control sample.   
Gene Symbol 
Fold-change BCM v 
Control 
Fold-change PCM v 
Control 
ARG1 (NO prod) -3.042 -2.499 
DUSP1 (NO prod) 9.061 - 
IL6 (NO prod) 4.623 - 
JUN (NO prod) 3.523 - 
ADM (NO prod) 2.917 - 
IL1B (NO prod) 2.586 - 
TNF (NO prod) 2.333 - 
IL1A (NO prod) 2.113 - 
















Chapter 3: Summary and Conclusions 
 
In an effort to better understand the effect of S. aureus biofilms on human keratinocytes, we 
treated human epithelial keratinocytes with secreted products from S. aureus bacteria grown planktonically 
and as a biofilm.  The secreted producets of S. aureus cell grown planktonically and as a biofilm were 
introduced to HEKa cells and data was collected to determine if there was a differential inflammatory 
response.  We hypothesized that S. aureus growing as biofilms actively promote inflammatory responses in 
human epithelial keratinocytes.  To test this hypothesis we performed a series of experiments to better 
understand differential response to S. aureus bacterial biofilms.  
To test inflammatory responses we evaluated differential gene expression in HEKa cells treated 
with the BCM, PCM and control conditions.  Transcriptional profiling was done using illumine microarray 
technology.  The data from the microarray analysis was filtered to identify genes associated with 
inflammation, apoptosis, and nitric oxide production.  In the case of inflammation, apoptosis and nitric 
oxide produced the HEKa cells treated with BCM showed an increase of genes transcribed.  To confirm the 
increased inflammatory response seen in the microarray data we performed an ELISAs on five different 
cytokines and chemokines.  We chose to test IL-1, IL-6, IL-8,TNF-α, and CXCL2 which are cytokines that 
are commonly produced by keratinocytes in response to infection [Secor et al., 2011].  ELISA assays were 
done on HEKa cells at four and eight hours after treatment with BCM, PCM, or control conditions.  After 
four hours there was a significant difference in the production of IL-6, TNF-α and CXCL2 between HEKa 
cells treated with S. aureus cells grown in biofilms and cells grown planktonically and under control 
conditions.  After eight hours, in addition to IL-6, TNF-α, and CXCL2, IL-8 production was also 
significantly elevated in HEKa cells exposed to BCM compared to HEKa cells exposed to PCM or control 
conditions.  These data confirmed that there was a differential inflammatory response.  Further studies are 
wanted to determine what secreted components or combination of secreted components from S. aureus 
biofilms cause the increased inflammatory response.     
One of the more surprising findings in this survey was the upregulation of genes associated with 





confirmed that there was a significant increase in the production of nitric oxide in HEKa cells exposed to 
BCM when compared to nitric oxide levels of HEKa cells exposed to PCM and control conditions.   
As a part of the normal inflammatory process some loss of cell viability is expected.  In this study 
microarray analysis showed that genes associated with apoptosis were more highly expressed in HEKa 
cells treated with BCM than HEKa cells treated with PCM or control conditions.  Cell viability assays also 
showed that there was a greater loss of cell viability   in HEKa cells treated with BCM.  Furthur studies are 
needed to determine if the loss of cell viability is due to apoptosis or necrosis and possibly how that relates 
to cytokine or NO production.   
The results of all of these tests indicate that products secreted by S. aureus growing in biofilms 
actively promote inflammatory responses in human keratinocytes, which may play a direct role in the 
prolonged inflammation and lack of re-epithelialization of chronic wounds.  Work will now focus on 
identifying the products in S. aureus biofilm secretions that promote chronic inflammation and lack of re-
epithelialization, as well as understanding the role of nitric oxide in chronic wound pathogenesis.  Future 
work involving mouse wound models may be valuable in determining if the supernatants can inhibit 
healing in a real wound.  This study looked at one particular strain of S. aureus but future studies should 
also evaluate the effects of supernatants from different strains of S. aureus to determine if there are 
different inflammatory effects.  The use of different strains of the bacterium may determine if the 
inflammatory promoting factors are strain specific or highly conserved among strains.  The fundamentally 
new knowledge gained through this work is expected to foster the development of more effective 
treatments, which will promote the healing process and ultimately reduce the amount of morbidity, 











Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A.  Tumor necrosis factor alpha suppresses 
the induction of connective tissue growth factor by transforming growth factor-beta in normal 
and scleroderma fibroblasts. J Biol Chem. 2000. 275 (20):15220-15225. 
Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines IL 6 and related 
molecules (IL1 and TNF). FASEB 1990. 4 (11): 2860- 2867.  
 
Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-α (TNF-α) in epidermal 
keratinocytes revealed using global transcriptional profiling. J Biol Chem. 2004. 279(31): 32633-
32642.  
 
Baron S. Medical microbiology 4
th
 edition. University of Texas Medical Branch at Galveston. 1996. 
Chapter 12.  
 
Barraud N, Schleheck D, Klebensberger, Webb JS, Hassat DJ, Rice SA, Kjelleberg S. Nitric oxide 
signaling in Pseudomonas aeriginosa biofilms mediates phosphodiesterase activity, decreased 
cyclic di-GMP levels, and enhanced dispersal. J Bacteriol. 2009. 191 (23): 7333-7342.  
 
Beckrich K, Aronovitch SA. 1999.  Hospital-acquired pressure ulcers: a comparison of costs in 
medical vs. surgical patients. Nurs Econ. 1999. 17: 263-271. 
 
Beeken KE, Blevins JS, Smeltzer MS, Mutations of sarA in Staphylococcus aureus limits biofilm 
formation.  Infect. Immun. 2003. 71(7): 4206-4211.  
 
Beenken KE, Blevins JS, Smeltzer MS. Mutation of sarA in Staphylococcus aureus limits biofilm 
formation. Infect. Immun. 2003. 71:4206-11. 
 
Benjamini, Y; Hochberg, Y. Controlling the false discovery rate: a practical and powerful 
approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological) 
1995. 57(1): 289–300.  
 
Boyko EJ, Ahroni JH, Smith DG, Davignon D.  Increased mortality associated with diabetic foot 
ulcers.  Diabetic Med. 1996. 13(11): 967-972. 
 
Bruch-Gerharz D, Schnorr O, Suschek C, Beck KF, Pfeilschifter J, Ruzicka T, Kolb-Bachofen V. 
Arginase 1 Overexpression in Psoriasis: Limitation of Inducible Nitric Oxide Synthase Activity 
as a Molecular Mechanism for Keratinocyte Hyperproliferation. Am J Path. 2003. 162(1): 203-
211. 
 
Cai W, Wu J, Xi C, Meyerhoff ME. Diazeniumdiolate-doped poly (lactic-co-glycolic acid)-based 
nitric oxide releasing films as antibiofilm coating. Biomaterials 2012. 33 (32):7933-7944. 
 
Chaignon  P. Sadovskaya I. Ragunah C. Ramasubbu N. Kaplan JB. Jabbouri S. Susceptibility of 
staphylococcal biofilms to enzymatic treatments depends on their chemical composition. Appl 
Microbiol Biotechmol. 2007. 75: 125-132.  
 
Campoccia D, Baldassarri L, Pirini V, Ravioli S, Montanaro L, Arciola CR. Molecular epidemiology 
of staphylococcus aureus from implant orthopedic infections: Ribotypes, agr. Polymorphism, 








Cook H, Stephens P, Davis KJ, Harding KG, Thomas DW. Defective extracellular matrix 
reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, 
and MMP-2 activity. J Invest Dermatol. 2000, 115 (2):225-233. 
 
Costerton JW, Montanaro L, Arciola CR. Bacterial communications in implant infections: a target 
for an intelligence war. The international Journal of Artificial Organs. 2007. 30 (9): 757-763. 
 
Crampton SE, Gerke C, Schnell NF, Nichols WW, Götz. The intracellular adhesion (ica) locus is 
present in Staphylococcus aureus and is required for biofilm formation. Infect. Immun. 1999. 
67:5427-33.  
 
Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F. The intercellular adhesion (ica) locus is 
present in staphylococcus aureus and is required for biofilm formation. Inf and Immun. 1999. 
67(10): 5427-5433. 
 
Cucarella C, Solano C, Valle J, Amorena B, Lasa I, Penades JR. Bap, a Staphylococcus arues surface 
protein involved in biofilm formation. J Bacteriol. 2001. 183(9):2888-2896. 
 
Cuenda A, Rousseau S. P38 MAP-Kinases pathway regulation, function and role in human 
diseases.  Biochemica Biophysica Acta 2007. 1773 (8):1358-1375.  
 
Darby I. Skalli O. Gabbiani G. Alpha-smooth muscle actin transiently expressed by 
myofibribroblasts during experimental wound healing.  Laboratory Investigations. 1990. 63(1): 21-
29.  
 
Dauwalder O, Thomas D, Ferry T, Debard A-L, Badiou C, Vandenesch F, Etienne J, Lina G, Monneret 
G. Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and 
SEG: implications for septic shock. J. Leuk. Biol. 2006. 80:753-758. 
 
Deluané A, Dubrac S, Blanchet C, Poupel O, Mäder U, Hiron A, Leduc A, Fitting C, Nicolas P, 
Cavaillon J-M, Adib-Conquy M, Msadek T. The WalkR system controls major staphylococcal 
virulence genes and is involved in triggering the host inflammatory response. Infect. Immun. 
2012. 80:3438-53. 
 
Edwards AM, Bowden MG, Brown EL, Laabei M, Massey RC, Staphylococcus aureus extracellular 
adherence protein triggers TNF-α release promoting attachment to endothelial cells via protein 
A. 2012. PLos ONE 7 (8): e43046. 
 
Edwards R and Harding KG. Bacteria wound healing. Current opinions in Infectious Diseases. 2004. 
17:91-96. 
 
Epstein FH. Mechanisms of disease: Neuroendocrine-immune interactions.  N Engl J Med. 1993. 




, Sherry B, Tracey KJ, van Deventer S, Jones WG 2
nd
, Minei JP. Cytokine production in 
a model of wound healing; the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine. 
1990. 2 (2):92-99. 
 
Falsetta ML, McEwan AG, Jennings MP, Apicella MA. Anaerobic metabolism occurs in the 
substrate of gonococcal biofilms and may be sustained in part by nitric acid. Infect and Immun. 
2010. 78:2320-2328. 
 
Fletcher J. Differences between acute and chronic wounds and the role of wound bed preparation. 






Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin. 
Microbiol. Rev. 2005. 18:521–540. 
 
Frank S, Kampfer H, Wetzler C, Pfeilschifter J. Nitric oxide drives skin repair: novel functions of 
an established mediator. Kidney International. 2002. 61(3):882-888. 
 
Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR-LuxI Family of cell 
density-responsive transcriptional regulators. J Bacteriol. 1994. 176 (2):269-75. 
 
Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA. Multiple bacterial 
species reside in chronic wounds: a longitudinal study.  International Wound Journal. 2006. 
3(3):225-31. 
 
Gotz F. Staphylococcus and biofilms. Mol Microbiol. 2002. 43(6): 1367-1378. 
  
Granger, D. L., J. B. Hibbs, and L. M. Broadnax. Urinary nitrate excretion in relation to murine 
macrophage activation: influence of dietary l-arginine and oral N
G
-monomethyl-l-arginine. J. 
Immunol. 1991. 146:1294-1302. 
 
Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Badavias E, Falanga V. Dermal fibroblasts from 
venous ulcers are unresponsive to action of transforming growth factor-beta 1.  J Dermatol Sci. 
1997. 16(1):59-66. 
 
Hashioka S, Klegeris a, Moni A, Kato T, Sawada M, McGreer PL, Kanba S. Antidepressants inhibit 
interferon-γ-induced microglial production of IL-6 and nitric oxide. Exp Neurol. 2007. 206(1):33-
42.  
 
Heck DE, Laskin DL, Gardner CR, Laskin JD. Epidermal growth factor suppresses nitric oxide and 
hydrogen peroxide production by keratinocytes. J Biol Chem. 1992. 267(30): 21277-21280. 
 
James GA, Swogger E, Wolcott R, Pulcini E, Secor J, Sestrich J, Costerton JW, Stewart PS. Biofilms 
in chronic wounds. Wound Repair Regen. 2008. 16 (1):37-44. 
 
Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Nesme X, Etienne J, Vandenesch F. 
Relationship between staphylococcus aureus genetic backgrouns virulence factor agr 
groups(alleles), and human disease. Infect and Immun.2002. 70 (2): 631-641.   
 
Jones ML, Ganapolsky JG, Labbe A, Wahl C, Prakash S. Antimicrobial properties of nitric oxide 
and its application in antimicrobial formulations and medical devices. Appl Microbiol Biot. 2010. 
88(2): 401-407.  
 
Kirker KR, Secor PR, James GA, Fleckman P, Olerud JE, Stewart PS.  Loss of viability and 
induction in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound 
Repair and Reg. 2009. 17(5):690-699. 
 
Konig B, Prevost G, Piemont Y, Konig W. Effects of Staphylococcus aureus leukocidins on 
inflammatory mediator release from human granulocytes. J. Infect. Dis. 1995. 171:607–613. 
 
Landi F, Onder G, Russo A, Bernabei R. Pressure ulcer and mortality in frail elderly people living 
in community. Arch Gerontol Geriat. 2007. 44:217-223. 
 
Lina G, Piemont Y, Godail-Gamont F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J. 
Involvement of Panton-Valentine leukocidin—producing staphylococcus aureus in primary skin 






Liu YX, Wang J, Guo J, Wu J, Lieberman HB, Yin Y. DUSP1 is controlled by p53 during cellular 
response to oxidative stress. Mol Cancer Res. 2008. (4):624-633.  
 
Loo AEK, Halliwell B. Effects of hydrogen peroxide in a keratinocyte-fibroblast    co-culture 
model of wound healing. Biochem Bioph Res Co. 2012. 423(2): 253-258.  
 
Luo JD, Chen AF. Nitric oxide: a newly discovered function on wound healing. Acta 
Pharmacologica Sinica 2005. 26(3): 259-264.  
 
Mempel M, Schmidt T, Weidinger S, Schnopp C, Foster T, Ring J, Abect D. Role of Staphylococcus 
aureus surface-associated proteins in the attachment of cultured HaCaT keratinocytes in a new 
adhesion assay. The Society for Investigative Dermatology. 1998. 111(3): 452-456. 
 
Mempel M, Voelcker V, Kollisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli A, 
Ring J, Abeck D, Ollert M. Toll-like receptor expression in human keratinocytes: nuclear factor 
kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-
like receptor 4 or platelet activating factor receptor dependent.  J Invest Dermatol 2003. 121(6): 
1389-1396.  
 
Menon SN, Flegg JA, McCue SW, Schugart RC, Dason RA, McElwain DLS. Modeling the 
interaction of keratinocytes and fibroblasts during the normal and abnormal wound healing 
processes. Proc. R. Soc.  2012.279: 3329-3338.  
 
Miller LS. Toll-like receptors in skin. Adv Dermatol 2008. 24:71-87. 
 
Nakane A, Okamoto M, Asano M, Kohanawa M, Minigawa T. Endogenous gamma interferon, 
tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect. 
Immun. 1995. 63:1165–72. 
 
Newton K, Dixit VM. Signaling in Innate Immunity and Inflammation. Cold Spring Harb Perspect 
Biol. 2012. 4(3):1-19.  
 
O’Riordan K, Lee JC, Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 
2004.17(1): 218. 
 
Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, O’Neill G, Day NP. Virulent 
combinations of adhesions and toxin genes in natural populations of Staphylococcus aureus. 
Infect. Immun. 2002. 70(9):4978-4996. 
 
Resch A, Rosenstein R, Nerz C, Götz. Differential gene expression profiling of Staphylococcus 
aureus cultivated under biofilm and planktonic conditions. Appl. Environ. Microbiol. 2005. 
71:2663-76. 
 
Rizk M, Witte MB, Barul A. Nitric oxide and wound healing. World J Surg. 2004. 28(3):301-306. 
 
Schaffer MR, Tantry U, Gross SS, Wasserkruc HL, Barbui A. Nitric oxide regulated wound healing.  
J Surg Res. 1996. 63(1):237-240.  
 
Schierle CF, De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound 
healing by delaying reepithelialzation in a murine cutaneous wound model. Wound Repair Regen. 
2009. 17(3):354-359.  
 
Schieven GL. The p38 kinase plays a central role in inflammation. Curr Top Med Chem. 2009. 






Schnorr O, Suschek CV, Kolb-Bachofen. The importance of cationic amino acid transporter 
expression in human skin. J. Invest. Dermatol. 2003. 120:1016-1022. 
 
Secor PA, Garth JA, Fleckman P, Olerud JE, Mclnnemey K, Stewart PS. Staphylococcus aureus 
biofilm and planktonic cultures differentially impact gene expression, mapk phosphorylation, 
and cytokine production in human keratinocytes. BMC Microbiology. 2011. 11(1):143-155. 
 
Serralta VW, Harrison Belestra C, Cazzaniga AL, Davis SC, Mertz PM. Lifestyles of bacteria in 
wounds: presence of biofilms?  Wounds. 2001. 13:29-34.  
 
Siddiqui AR, Berstein JM. Chronic wound infections: facts and controversies. Clinics in 
Dermatology 2010. 28:519-526.  
 
Singer AJ. Clark RAF. Cutaneous wound healing. N Engl J Med. 1999. 341(10): 738- 746. 
 
Soneja A, Drews M, Malinski T. Role of nitric oxide, nitroxidative and oxidative stress in wound 
healing. Pharmacol Rep. 2005. 57:108-119.  
 
Stadelmann  WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous 
wounds. Journal of Surgery. 1998. 176(2): 26-38.  
 
Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms.  Lancet. 2001. 
358(9276):135-138. 
 
Stojadinovic O, Brenn H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, 
Tomic-Canic M. Molecular pathogenesis of chronic wounds:  The role of β-catenin and c-myc in 
the inhibition of epithelialization and wound healing. Am J Path. 2005. 167 (1):59-69. 
 
Thurlow LR, Hanke MI, Fritz T, Angle A, Aldrich A, Williams SH, Engebretsen II, Bayles KW, 
Horswill AR, Kielian T. Staphylococcus aureus biofilms prevent macrophage phagocytosis and 
attenuate inflammation in vivo. J Immunol 2011. 186 (11):6585-6596.  
 
Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Analysis of acute and chronic wound 
environments:  Mitogenic activity and cytokine levels in non-healing and healing chronic leg 
ulcers. Wound Rep Regen. 2000. 8:13-25. 
 
Valle JA, Toledo-Arana A, Berasain C, Ghigo J, Amorena B, Penades JR, Lasa I. SarA and not δ
B
 is 
essential for biofilm development by Staphylococcus aureus. Mol. Microbiol. 2003. 48:1075-87. 
 
Walev I, Weller U, Strauch S, Foster T,  Bhakdi S. Selective killing of human monocytes and 
cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus. Infect. 
Immun. 1996. 64:2974-79. 
 
Wang JE, Dahle MK, Yndestad, Bauer I, McDonald MC,  Aukrust P, Foster SJ, Bauer M, Aasen AO, 
Thiermermann C. Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury 
in the rat. Crit. Care Med. 2004. 32:546-552. 
 
Wang JE, Jorgensen PF, Almӧf  M, Thiermermann C, Foster SJ,  Aasen AO, Solberg R. 
Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor 
Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human 
Whole Blood Model. Infect. Immun. 2000. 81:3965-70. 
 
Waters CM, Bassler BL. Quorum sensing: cell-to-cell communication in bacteria.  Annu Rev Cell 






Wertheim HF, Melles DC, Vos MC, van Leeuwen W, Belkum A, Verbrugh HA, Nouwen JL. The role 
of nasal carriage in staphylococcus aureus infections. Lanceet Infect Dis. 2005. 5:751-762.   
 
Yamaguchi T, Nishifuji K, Sasaki M, Fudaba , Aepfelbacher M, Takata T, Ohara M, Komatsuawa H, 
Amagai M, Sugai M. Identification of the staphylococcus aureus etd pathogenicity island which 
encodes a novel exfoliative toxin, ETD, and EDIN-B. Inf and Immun. 2002. 70(10): 5835-5845. 
 
 
 
 
 
 
 
 
 
 
  
